His Optics study frequently draws connections to other fields, such as Incidence (geometry). Incidence (geometry) is frequently linked to Optics in his study. He regularly ties together related areas like Sex ratio in his Demography studies. Much of his study explores Sex ratio relationship to Population. His Demography research extends to the thematically linked field of Population. Barry E. Storer combines Cancer research and Melanoma in his research. In his research, Barry E. Storer performs multidisciplinary study on Melanoma and Cancer research. His Internal medicine study frequently links to other fields, such as Comorbidity. Comorbidity connects with themes related to Internal medicine in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
Ted A. Gooley;Ted A. Gooley;Wendy Leisenring;Wendy Leisenring;John Crowley;John Crowley;Barry E. Storer;Barry E. Storer.
Statistics in Medicine (1999)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Mohamed L. Sorror;Michael B. Maris;Michael B. Maris;Rainer Storb;Rainer Storb;Frederic Baron.
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers
William I. Bensinger;Paul J. Martin;Barry Storer;Reginald Clift.
The New England Journal of Medicine (2001)
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases
Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf.
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee.
Long-term survival among men with conservatively treated localized prostate cancer.
Peter C. Albertsen;Dennis G. Fryback;Barry E. Storer;Thomas F. Kolon.
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
Bianca D. Lemos;Barry E. Storer;Jayasri G. Iyer;Jerri Linn Phillips.
Journal of The American Academy of Dermatology (2010)
Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation
Mohamed L. Sorror;Brenda M. Sandmaier;Barry E. Storer;Michael B. Maris.
Journal of Clinical Oncology (2007)
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Mary E. D. Flowers;Pablo M. Parker;Laura J. Johnston;Alice V. B. Matos.
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Jan Storek;Monja A. Dawson;Barry Storer;Terry Stevens-Ayers.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: